PSYCHEMEDICS CORPORATION CMN - COM (PMD)

CUSIP: 744375205

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COM
Total 13F shares
1,431,884
Share change
+46,447
Total reported value
$5,683,476
Price per share
$3.97
Number of holders
24
Value change
+$174,775
Number of buys
9
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 744375205?
CUSIP 744375205 identifies PMD - PSYCHEMEDICS CORPORATION CMN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PSYCHEMEDICS CORPORATION CMN - COM (PMD) as of Q3 2023

As of 30 Sep 2023, PSYCHEMEDICS CORPORATION CMN - COM (PMD) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,431,884 shares. The largest 10 holders included 22NW, LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, RBF Capital, LLC, Ancora Advisors, LLC, BlackRock Inc., CANNELL CAPITAL LLC, WEDBUSH SECURITIES INC, WEALTH EFFECTS LLC, and DIMENSIONAL FUND ADVISORS LP. This page lists 24 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.